Amicus Therapeutics Inc (FOLD): Next-Year EPS Estimate 82.61%
As of 2026-05-07, Amicus Therapeutics Inc (FOLD) has a next-year EPS growth estimate of 82.61%.
On 2026-04-30, analyst consensus for FOLD's next-year EPS growth shifted from 120.55% to 82.61% — a negative change of 37.94 percentage points. The revised estimate has been sustained across 6 subsequent trading sessions. Current-year growth is projected at 611.11%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 82.61%
- EPS growth this year
- 611.11%
- EPS next quarter (est)
- $0.06
- Last price
- $14.49
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-05-07 | 82.61% | 611.11% | $0.06 | $14.49 |
| 2026-05-06 | 82.61% | 611.11% | $0.06 | $14.49 |
| 2026-05-05 | 82.61% | 611.11% | $0.06 | $14.49 |
| 2026-05-04 | 82.61% | 611.11% | $0.06 | $14.49 |
| 2026-05-03 | 82.61% | 611.11% | $0.06 | $14.49 |
| 2026-04-30 | 82.61% | 611.11% | $0.06 | $14.49 |
| 2026-04-29 | 120.55% | 505.56% | $0.04 | $14.49 |
| 2026-04-28 | 120.55% | 505.56% | $0.04 | $14.49 |
| 2026-04-27 | 79.44% | 496.30% | $0.05 | $14.49 |
| 2026-04-26 | 79.44% | 496.30% | $0.05 | $14.49 |
| 2026-04-24 | 79.44% | 496.30% | $0.05 | $14.49 |
| 2026-04-23 | 79.44% | 496.30% | $0.05 | $14.46 |
| 2026-04-22 | 79.44% | 496.30% | $0.05 | $14.46 |
| 2026-04-21 | 79.44% | 496.30% | $0.05 | $14.46 |
| 2026-04-20 | 79.44% | 496.30% | $0.05 | $14.46 |
| 2026-04-19 | 79.44% | 496.30% | $0.05 | $14.46 |
| 2026-04-16 | 79.44% | 496.30% | $0.05 | $14.45 |
| 2026-04-15 | 79.44% | 496.30% | $0.05 | $14.46 |
| 2026-04-14 | 88.55% | 463.89% | $0.04 | $14.46 |
| 2026-04-13 | 88.55% | 463.89% | $0.04 | $14.46 |
| 2026-04-12 | 88.55% | 463.89% | $0.04 | $14.46 |
| 2026-04-10 | 88.55% | 463.89% | $0.04 | $14.47 |
| 2026-04-09 | 88.55% | 463.89% | $0.04 | $14.47 |
| 2026-04-08 | 88.55% | N/A | $0.04 | $14.46 |
| 2026-04-07 | 88.55% | N/A | $0.04 | $14.47 |
| 2026-04-06 | 88.55% | N/A | $0.04 | $14.47 |
| 2026-04-05 | 88.55% | N/A | $0.04 | $14.44 |
| 2026-04-03 | 88.55% | N/A | $0.04 | $14.47 |
| 2026-04-02 | 88.55% | N/A | $0.04 | $14.47 |
| 2026-04-01 | 88.55% | N/A | $0.04 | $14.47 |
Recent News
- BioMarin acquires Amicus Therapeutics for $4.8bnPharmaceutical Business Review
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Amicus Therapeutics Inc's next-year EPS growth estimate?▾
As of 2026-05-07, Amicus Therapeutics Inc (FOLD) has a next-year EPS growth estimate of 82.61%, based on analyst consensus.
When was the latest EPS estimate revision for FOLD?▾
The most recent revision occurred on 2026-04-30, when analysts adjusted the next-year EPS growth estimate from 120.55% to 82.61%.
What sector and industry does Amicus Therapeutics Inc belong to?▾
Amicus Therapeutics Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. FOLD appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Amicus Therapeutics Inc (FOLD) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports